Source link : https://newshealth.biz/health-news/adc-pertuzumab-promising-as-new-standard-in-her2-positive-metastatic-breast-cancer/
(MedPage Today) — CHICAGO — First-line trastuzumab deruxtecan (T-DXd) combined with pertuzumab (Perjeta) improved progression-free survival (PFS) in HER2-positive locally advanced or metastatic breast cancer, according to the DESTINY-Breast09… Source link : https://www.medpagetoday.com/meetingcoverage/asco/115844 Author : Publish date : 2025-06-02 12:00:00 Copyright for syndicated content belongs to the linked Source.
The post ADC-Pertuzumab Promising as New Standard in HER2-Positive Metastatic Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-02 12:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8